ConferenceAffluent Medical Announces Participation in Upcoming Scientific Events 08.10.2024 / 17:45 CET/CESTThe issuer is solely responsible for the content of this announcement.PRESS RELEASE Affluent ...
Following positive feedback from the FDA in September 2024, Affluent Medical’s objective is to submit a De Novo application with current clinical data at the end of 2025/early 2026, followed by ...
Active funds pulled ahead of their passive peers, with a 4% success rate increase. It's difficult to choose between active vs. passive investing approaches. Though about 51% of actively managed ...